KEGG   PATHWAY: ccad04650
Entry
ccad04650                   Pathway                                
Name
Natural killer cell mediated cytotoxicity - Cervus canadensis (wapiti)
Description
Natural killer (NK) cells are lymphocytes of the innate immune system that are involved in early defenses against both allogeneic (nonself) cells and autologous cells undergoing various forms of stress, such as infection with viruses, bacteria, or parasites or malignant transformation. Although NK cells do not express classical antigen receptors of the immunoglobulin gene family, such as the antibodies produced by B cells or the T cell receptor expressed by T cells, they are equipped with various receptors whose engagement allows them to discriminate between target and nontarget cells. Activating receptors bind ligands on the target cell surface and trigger NK cell activation and target cell lysis. However Inhibitory receptors recognize MHC class I molecules (HLA) and inhibit killing by NK cells by overruling the actions of the activating receptors. This inhibitory signal is lost when the target cells do not express MHC class I and perhaps also in cells infected with virus, which might inhibit MHC class I exprssion or alter its conformation. The mechanism of NK cell killing is the same as that used by the cytotoxic T cells generated in an adaptive immune response; cytotoxic granules are released onto the surface of the bound target cell, and the effector proteins they contain penetrate the cell membrane and induce programmed cell death.
Class
Organismal Systems; Immune system
Pathway map
ccad04650  Natural killer cell mediated cytotoxicity
ccad04650

Other DBs
GO: 0042267
Organism
Cervus canadensis (wapiti) [GN:ccad]
Gene
122419670  [KO:K01353] [EC:3.4.21.79]
122419671  [KO:K01353] [EC:3.4.21.79]
122420118  PLCG2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 isoform X1 [KO:K05859] [EC:3.1.4.11]
122420171  PRKCG; protein kinase C gamma type [KO:K19663] [EC:2.7.11.13]
122420991  NCR1; natural cytotoxicity triggering receptor 1 isoform X1 [KO:K06741]
122421467  [KO:K07992]
122421468  HCST; hematopoietic cell signal transducer isoform X1 [KO:K07988]
122422203  PPP3CA; serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X1 [KO:K04348] [EC:3.1.3.16]
122422629  FYN; tyrosine-protein kinase Fyn isoform X1 [KO:K05703] [EC:2.7.10.2]
122422795  PTPN11; tyrosine-protein phosphatase non-receptor type 11 isoform X1 [KO:K07293] [EC:3.1.3.48]
122423034  BID; BH3-interacting domain death agonist isoform X1 [KO:K04726]
122423661  RAC2; ras-related C3 botulinum toxin substrate 2 [KO:K07860]
122423732  [KO:K06541]
122423733  [KO:K06541]
122423734  [KO:K06541]
122423735  [KO:K06541]
122423736  [KO:K06541]
122423738  [KO:K06541]
122423740  [KO:K06541]
122423792  PTPN6; tyrosine-protein phosphatase non-receptor type 6 isoform X1 [KO:K05697] [EC:3.1.3.48]
122423857  [KO:K06728]
122423876  KRAS; GTPase KRas isoform X1 [KO:K07827]
122423927  [KO:K06541]
122424030  [KO:K06516]
122424062  [KO:K06516]
122424748  PRKCA; protein kinase C alpha type isoform X1 [KO:K02677] [EC:2.7.11.13]
122425059  RAF1; RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
122425388  NFATC1; nuclear factor of activated T-cells, cytoplasmic 1 isoform X1 [KO:K04446]
122426634  LCK; tyrosine-protein kinase Lck [KO:K05856] [EC:2.7.10.2]
122427438  IFNG; interferon gamma [KO:K04687]
122428175  SH3BP2; SH3 domain-binding protein 2 isoform X1 [KO:K07984]
122428739  IFNAR1; interferon alpha/beta receptor 1 isoform X1 [KO:K05130]
122428743  IFNAR2; interferon alpha/beta receptor 2 isoform X1 [KO:K05131]
122428752  IFNGR2; interferon gamma receptor 2 isoform X1 [KO:K05133]
122429592  [KO:K07985]
122429595  [KO:K07985]
122429596  [KO:K07985]
122429597  [KO:K07985]
122429598  [KO:K07985]
122429687  CD247; T-cell surface glycoprotein CD3 zeta chain isoform X1 [KO:K06453]
122429891  NCR3; natural cytotoxicity triggering receptor 3 [KO:K06743]
122429940  [KO:K07985]
122430042  SH2D1B; SH2 domain-containing protein 1B isoform X1 [KO:K07989]
122430072  TNF; tumor necrosis factor [KO:K03156]
122430259  [KO:K06463]
122430454  FCER1G; high affinity immunoglobulin epsilon receptor subunit gamma [KO:K07983]
122430591  HRAS; GTPase HRas isoform X1 [KO:K02833]
122430687  PAK1; serine/threonine-protein kinase PAK 1 isoform X1 [KO:K04409] [EC:2.7.11.1]
122430738  CD244; natural killer cell receptor 2B4 isoform X1 [KO:K06582]
122430795  CD48; CD48 antigen [KO:K06479]
122431708  PPP3CC; serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X1 [KO:K04348] [EC:3.1.3.16]
122431762  SHC3; SHC-transforming protein 3 isoform X1 [KO:K17448]
122431765  SYK; tyrosine-protein kinase SYK isoform X1 [KO:K05855] [EC:2.7.10.2]
122431820  PTK2B; protein-tyrosine kinase 2-beta isoform X1 [KO:K05871] [EC:2.7.10.2]
122431959  PPP3R2; calcineurin subunit B type 2 [KO:K06268]
122432087  [KO:K04722]
122432089  [KO:K04722]
122432443  CASP3; caspase-3 isoform X1 [KO:K02187] [EC:3.4.22.56]
122432839  SHC1; SHC-transforming protein 1 isoform X1 [KO:K06279]
122433033  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
122433081  PRKCB; protein kinase C beta type isoform X1 [KO:K19662] [EC:2.7.11.13]
122433147  LAT; linker for activation of T-cells family member 1 isoform X1 [KO:K07362]
122433163  LAT2; linker for activation of T-cells family member 2 isoform X1 [KO:K26356]
122433321  RAC1; ras-related C3 botulinum toxin substrate 1 isoform X1 [KO:K04392]
122433358  ITGAL; integrin alpha-L isoform X1 [KO:K05718]
122433850  [KO:K07986]
122433852  [KO:K07987]
122433854  [KO:K07986]
122433855  [KO:K07986]
122433858  [KO:K07986]
122433860  [KO:K07986]
122433863  [KO:K07986]
122433865  [KO:K07986]
122433870  [KO:K07986]
122433969  IFNGR1; interferon gamma receptor 1 isoform X1 [KO:K05132]
122434589  ARAF; serine/threonine-protein kinase A-Raf isoform X1 [KO:K08845] [EC:2.7.11.1]
122435868  SH2D1A; SH2 domain-containing protein 1A [KO:K07990]
122435924  NRAS; GTPase NRas [KO:K07828]
122436609  VAV3; guanine nucleotide exchange factor VAV3 [KO:K05730]
122436698  GRB2; growth factor receptor-bound protein 2 [KO:K04364]
122437038  PIK3R3; phosphatidylinositol 3-kinase regulatory subunit gamma isoform X1 [KO:K02649]
122438676  RAC3; ras-related C3 botulinum toxin substrate 3 [KO:K07861]
122438725  BRAF; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
122439279  CSF2; granulocyte-macrophage colony-stimulating factor [KO:K05427]
122439532  [KO:K06523]
122439548  [KO:K06523]
122439578  [KO:K06523]
122440231  [KO:K04369] [EC:2.7.12.2]
122440314  VAV1; proto-oncogene vav [KO:K05730]
122440432  ICAM1; intercellular adhesion molecule 1 [KO:K06490]
122440740  PIK3R2; LOW QUALITY PROTEIN: phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
122440910  [KO:K04369] [EC:2.7.12.2]
122441383  [KO:K07360] [EC:2.7.10.2]
122441591  SOS1; son of sevenless homolog 1 isoform X1 [KO:K03099]
122441856  PPP3R1; calcineurin subunit B type 1 [KO:K06268]
122442367  VAV2; guanine nucleotide exchange factor VAV2 isoform X1 [KO:K05730]
122443062  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 isoform X1 [KO:K04368] [EC:2.7.12.2]
122443464  SOS2; son of sevenless homolog 2 isoform X1 [KO:K03099]
122443633  SHC4; SHC-transforming protein 4 [KO:K17449]
122444906  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
122444929  TNFSF10; tumor necrosis factor ligand superfamily member 10 isoform X1 [KO:K04721]
122445271  [KO:K00922] [EC:2.7.1.153]
122445429  ITGB2; integrin beta-2 [KO:K06464]
122446047  [KO:K07827]
122446062  [KO:K04369] [EC:2.7.12.2]
122446181  FAS; tumor necrosis factor receptor superfamily member 6 isoform X1 [KO:K04390]
122446399  PPP3CB; serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform X1 [KO:K04348] [EC:3.1.3.16]
122446598  PRF1; perforin-1 [KO:K07818]
122447261  [KO:K04371] [EC:2.7.11.24]
122448567  [KO:K04392]
122448615  NFATC2; nuclear factor of activated T-cells, cytoplasmic 2 isoform X1 [KO:K17332]
122448704  PLCG1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 [KO:K01116] [EC:3.1.4.11]
122451688  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
122452409  FASLG; tumor necrosis factor ligand superfamily member 6 [KO:K04389]
122452471  [KO:K07293] [EC:3.1.3.48]
122452950  [KO:K05414]
122452998  [KO:K05414]
122452999  [KO:K05414]
122453000  [KO:K05414]
122453001  [KO:K05414]
122453141  [KO:K05414]
122453310  [KO:K05414]
122453350  [KO:K05414]
122453394  [KO:K05415]
122453395  [KO:K05415]
122453396  [KO:K05415]
122453397  [KO:K05415]
122453398  [KO:K05415]
122453400  [KO:K05415]
122454326  LCP2; lymphocyte cytosolic protein 2 isoform X1 [KO:K07361]
122454626  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
122455089  [KO:K01353] [EC:3.4.21.79]
122455090  [KO:K01353] [EC:3.4.21.79]
122455092  [KO:K01353] [EC:3.4.21.79]
122455194  [KO:K01353] [EC:3.4.21.79]
122455234  [KO:K01353] [EC:3.4.21.79]
122455266  [KO:K01353] [EC:3.4.21.79]
122455309  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
Compound
C00076  Calcium cation
C00165  Diacylglycerol
C01245  D-myo-Inositol 1,4,5-trisphosphate
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Chiesa S, Tomasello E, Vivier E, Vely F.
  Title
Coordination of activating and inhibitory signals in natural killer cells.
  Journal
Mol Immunol 42:477-84 (2005)
DOI:10.1016/j.molimm.2004.07.030
Reference
  Authors
Maghazachi AA.
  Title
Insights into seven and single transmembrane-spanning domain receptors and their signaling pathways in human natural killer cells.
  Journal
Pharmacol Rev 57:339-57 (2005)
DOI:10.1124/pr.57.3.5
Reference
  Authors
Vivier E, Nunes JA, Vely F.
  Title
Natural killer cell signaling pathways.
  Journal
Science 306:1517-9 (2004)
DOI:10.1126/science.1103478
Reference
  Authors
Colucci F, Di Santo JP, Leibson PJ.
  Title
Natural killer cell activation in mice and men: different triggers for similar weapons?
  Journal
Nat Immunol 3:807-13 (2002)
DOI:10.1038/ni0902-807
Reference
  Authors
Perussia B.
  Title
Signaling for cytotoxicity.
  Journal
Nat Immunol 1:372-4 (2000)
DOI:10.1038/80808
Reference
  Authors
Smyth MJ, Cretney E, Kelly JM, Westwood JA, Street SE, Yagita H, Takeda K, van Dommelen SL, Degli-Esposti MA, Hayakawa Y.
  Title
Activation of NK cell cytotoxicity.
  Journal
Mol Immunol 42:501-10 (2005)
DOI:10.1016/j.molimm.2004.07.034
Reference
  Authors
Djeu JY, Jiang K, Wei S.
  Title
A view to a kill: signals triggering cytotoxicity.
  Journal
Clin Cancer Res 8:636-40 (2002)
Reference
  Authors
Smyth MJ, Takeda K, Hayakawa Y, Peschon JJ, van den Brink MR, Yagita H.
  Title
Nature's TRAIL--on a path to cancer immunotherapy.
  Journal
Immunity 18:1-6 (2003)
DOI:10.1016/S1074-7613(02)00502-2
Reference
  Authors
Colonna M.
  Title
Fine-tuning NK cell responses: it's a family affair.
  Journal
Nat Immunol 6:961-2 (2005)
DOI:10.1038/ni1005-961
Reference
PMID:8942070
  Authors
Bonnema JD, Leibson PJ.
  Title
Signal transduction during NK cell activation.
  Journal
Chem Immunol 64:28-43 (1996)
Reference
  Authors
Tassi I, Presti R, Kim S, Yokoyama WM, Gilfillan S, Colonna M.
  Title
Phospholipase C-gamma 2 is a critical signaling mediator for murine NK cell activating receptors.
  Journal
J Immunol 175:749-54 (2005)
DOI:10.4049/jimmunol.175.2.749
Reference
PMID:9143705
  Authors
Rao A, Luo C, Hogan PG.
  Title
Transcription factors of the NFAT family: regulation and function.
  Journal
Annu Rev Immunol 15:707-47 (1997)
DOI:10.1146/annurev.immunol.15.1.707
Reference
  Authors
Wu J, Lanier LL.
  Title
Natural killer cells and cancer.
  Journal
Adv Cancer Res 90:127-56 (2003)
DOI:10.1016/S0065-230X(03)90004-2
Reference
  Authors
Cerwenka A, Lanier LL.
  Title
Natural killer cells, viruses and cancer.
  Journal
Nat Rev Immunol 1:41-9 (2001)
DOI:10.1038/35095564
Reference
  Authors
Blott EJ, Griffiths GM.
  Title
Secretory lysosomes.
  Journal
Nat Rev Mol Cell Biol 3:122-31 (2002)
DOI:10.1038/nrm732
Reference
  Authors
Lieberman J.
  Title
The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal.
  Journal
Nat Rev Immunol 3:361-70 (2003)
DOI:10.1038/nri1083
Reference
  Authors
Lord SJ, Rajotte RV, Korbutt GS, Bleackley RC.
  Title
Granzyme B: a natural born killer.
  Journal
Immunol Rev 193:31-8 (2003)
DOI:10.1034/j.1600-065X.2003.00044.x
Reference
  Authors
Liu D, Xu L, Yang F, Li D, Gong F, Xu T.
  Title
Rapid biogenesis and sensitization of secretory lysosomes in NK cells mediated by target-cell recognition.
  Journal
Proc Natl Acad Sci U S A 102:123-7 (2005)
DOI:10.1073/pnas.0405737102
Reference
PMID:9862693
  Authors
Trotta R, Puorro KA, Paroli M, Azzoni L, Abebe B, Eisenlohr LC, Perussia B.
  Title
Dependence of both spontaneous and antibody-dependent, granule exocytosis-mediated NK cell cytotoxicity on extracellular signal-regulated kinases.
  Journal
J Immunol 161:6648-56 (1998)
Reference
  Authors
Jevremovic D, Billadeau DD, Schoon RA, Dick CJ, Leibson PJ.
  Title
Regulation of NK cell-mediated cytotoxicity by the adaptor protein 3BP2.
  Journal
J Immunol 166:7219-28 (2001)
DOI:10.4049/jimmunol.166.12.7219
Related
pathway
ccad04010  MAPK signaling pathway
ccad04020  Calcium signaling pathway
ccad04060  Cytokine-cytokine receptor interaction
ccad04210  Apoptosis
ccad04630  JAK-STAT signaling pathway
KO pathway
ko04650   

DBGET integrated database retrieval system